NEWTON, Mass.----Clinical Data, Inc. announced today that its PGxHealth Division has completed enrollment in a pivotal Phase III study of Vilazodone, in development for the treatment of depression.
From: biz.yahoo.com
Clinical Data Completes Phase III Enrollment of Vilazodone for Depression
Posted by Ruslan Abuzant at 8:13 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment